MedTrace Logo

A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.

NCT00157885 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2006-06-26

No results posted yet for this study

Summary

The primary aim of the comparative trial is to assess the relative safety and efficacy of two artemisinin containing regimens: amodiaquine plus artesunate (AAQ) and artekin both administered once daily for 3 days.

Conditions

  • Malaria, Falciparum
  • Malaria, Vivax

Interventions

DRUG

Amodiaquine plus artesunate; Artekin

Sponsors & Collaborators

  • National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

    collaborator OTHER

  • Wellcome Trust

    collaborator OTHER

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • Menzies School of Health Research

    lead OTHER

Principal Investigators

  • Ric N Price, MD · Menzies School of Health Research

  • Emiliana Tjitra · National Institute of Health Research and Development, Jakarta, Indonesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2005-12-31

Countries

  • Indonesia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00157885 on ClinicalTrials.gov